Corey Compton

Corey Compton currently serves as the Head of US Marketing for Immuno-Oncology at AstraZeneca, bringing extensive experience in the pharmaceutical industry. Prior to this role, Corey held various positions at Bristol Myers Squibb, including Lead WW Commercialization for the CTLA-4 portfolio and Director of US Oncology Brand Strategy, managing significant aspects of a $7 billion US oncology business unit. Corey's earlier career involved roles in business development and research, including a fellowship at Blackstone, engagement in high-throughput research at the Broad Institute, and significant contributions at Brown University and NASA Langley Research Center. Corey holds an MBA from UNC Kenan-Flagler Business School, a Ph.D. and MA in Chemistry from Brown University, and a BS in Chemistry and Biology from William & Mary. Key areas of expertise include R&D strategic planning, portfolio strategy, clinical operations, and business development.